Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
21
Number of overlapping holdings
16.5%
% of XBI's 128 holdings also in IDNA
50.0%
% of IDNA's 46 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
CRISPR THERAPEUTICS AG | 1.9% | 4.6% | 1.9% |
|
BLUEPRINT MEDICINES CORP. | 1.7% | 5.6% | 1.7% |
|
BEAM THERAPEUTICS, INC. | 1.5% | 4.2% | 1.5% |
|
EXELIXIS INC | 1.3% | 5.4% | 1.3% |
|
REGENERON PHARMACEUTICALS | 1.3% | 5.2% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to IDNA
|
MIRATI THERAPEUTICS INC | 2.1% |
|
TG THERAPEUTICS INC | 1.6% |
|
IONIS PHARMACEUTICALS, INC. | 1.6% |
|
APELLIS PHARMACEUTICALS, INC. | 1.5% |
|
IMMUNOVANT INC | 1.4% |
|
SEATTLE GENETICS INC | 1.4% |
|
HALOZYME THERAPEUTICS INC | 1.4% |
|
BRIDGEBIO PHARMA, INC. | 1.4% |
|
VERTEX PHARMACEUTICALS INC | 1.4% |
|
IMMUNOGEN INC | 1.4% |
XBI Underweight Relative to IDNA
 |
BIONTECH SE SPONSORED ADR | -4.4% |
 |
SANOFI-AVENTIS | -4.4% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.2% |
|
EXELIXIS INC | -4.1% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -4.1% |
 |
ROCHE HOLDING LTD | -4.0% |
|
REGENERON PHARMACEUTICALS | -3.9% |
 |
BEIGENE, LTD. | -3.9% |
 |
GENMAB A/S | -3.9% |
|
BLUEPRINT MEDICINES CORP. | -3.9% |